188 related articles for article (PubMed ID: 21106941)
1. Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 2: clinical studies.
Lanzani C; Citterio L; Glorioso N; Manunta P; Tripodi G; Salvi E; Carpini SD; Ferrandi M; Messaggio E; Staessen JA; Cusi D; Macciardi F; Argiolas G; Valentini G; Ferrari P; Bianchi G
Sci Transl Med; 2010 Nov; 2(59):59ra87. PubMed ID: 21106941
[TBL] [Abstract][Full Text] [Related]
2. Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 1: experimental studies.
Ferrandi M; Molinari I; Torielli L; Padoani G; Salardi S; Rastaldi MP; Ferrari P; Bianchi G
Sci Transl Med; 2010 Nov; 2(59):59ra86. PubMed ID: 21106940
[TBL] [Abstract][Full Text] [Related]
3. Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach.
Ferrari P; Ferrandi M; Valentini G; Manunta P; Bianchi G
Med Hypotheses; 2007; 68(6):1307-14. PubMed ID: 17097240
[TBL] [Abstract][Full Text] [Related]
4. Rostafuroxin protects from podocyte injury and proteinuria induced by adducin genetic variants and ouabain.
Ferrandi M; Molinari I; Rastaldi MP; Ferrari P; Bianchi G; Manunta P
J Pharmacol Exp Ther; 2014 Nov; 351(2):278-87. PubMed ID: 25187430
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan.
Citterio L; Bianchi G; Scioli GA; Glorioso N; Bigazzi R; Cusi D; Staessen JA; Cavuto S; Ferrandi M; Lanzani C; Li X; Lau LF; Chiang CE; Wang TD; Wang KL; Ferrari P; Manunta P
Pharmacogenomics J; 2021 Jun; 21(3):346-358. PubMed ID: 33649520
[TBL] [Abstract][Full Text] [Related]
6. Rostafuroxin: an ouabain-inhibitor counteracting specific forms of hypertension.
Ferrari P
Biochim Biophys Acta; 2010 Dec; 1802(12):1254-8. PubMed ID: 20083196
[TBL] [Abstract][Full Text] [Related]
7. Ouabain-dependent signaling in caveolae as a novel therapeutic target for hypertension.
Ferrandi M; Molinari I; Bianchi G; Ferrari P
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):15-8. PubMed ID: 17535730
[TBL] [Abstract][Full Text] [Related]
8. Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin.
Staessen JA; Thijs L; Stolarz-Skrzypek K; Bacchieri A; Barton J; Espositi ED; de Leeuw PW; Dłużniewski M; Glorioso N; Januszewicz A; Manunta P; Milyagin V; Nikitin Y; Souček M; Lanzani C; Citterio L; Timio M; Tykarski A; Ferrari P; Valentini G; Kawecka-Jaszcz K; Bianchi G
Trials; 2011 Jan; 12():13. PubMed ID: 21235787
[TBL] [Abstract][Full Text] [Related]
9. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.
Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G
J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844
[TBL] [Abstract][Full Text] [Related]
10. OASIS-HT: design of a pharmacogenomic dose-finding study.
Staessen JA; Kuznetsova T; Acceto R; Bacchieri A; Brand E; Burnier M; Celis H; Citterio L; de Leeuw PW; Filipovský J; Fournier A; Kawecka-Jaszcz K; Manunta P; Nikitin Y; O'Brien ET; Redón J; Thijs L; Ferrari P; Valentini G; Bianchi G
Pharmacogenomics; 2005 Oct; 6(7):755-75. PubMed ID: 16207152
[TBL] [Abstract][Full Text] [Related]
11. Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension.
Ferrari P; Ferrandi M; Valentini G; Bianchi G
Am J Physiol Regul Integr Comp Physiol; 2006 Mar; 290(3):R529-35. PubMed ID: 16467500
[TBL] [Abstract][Full Text] [Related]
12. Genetics of primary hypertension: the clinical impact of adducin polymorphisms.
Citterio L; Lanzani C; Manunta P; Bianchi G
Biochim Biophys Acta; 2010 Dec; 1802(12):1285-98. PubMed ID: 20382219
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
14. [Association of polymorphism in alpha-adducin gene with antihypertensive effect of Hydrochlorothiazide].
Wu SL; Li DQ; Li HF; Yu Q; Li Y; Zhao HY
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Oct; 33(10):880-4. PubMed ID: 16266470
[TBL] [Abstract][Full Text] [Related]
15. Adducin and hypertension.
Staessen JA; Bianchi G
Pharmacogenomics; 2005 Oct; 6(7):665-9. PubMed ID: 16207143
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin system and alpha-adducin gene polymorphisms and their relation to responses to antihypertensive drugs: results from the GENRES study.
Suonsyrjä T; Hannila-Handelberg T; Fodstad H; Donner K; Kontula K; Hiltunen TP
Am J Hypertens; 2009 Feb; 22(2):169-75. PubMed ID: 19057513
[TBL] [Abstract][Full Text] [Related]
17. Losartan with hydrochlorothiazide in the treatment of hypertension.
Schoenberger JA;
J Hypertens Suppl; 1995 Jul; 13(1):S43-7. PubMed ID: 18800455
[TBL] [Abstract][Full Text] [Related]
18. A new antihypertensive agent that antagonizes the prohypertensive effect of endogenous ouabain and adducin.
Manunta P; Ferrandi M; Messaggio E; Ferrari P
Cardiovasc Hematol Agents Med Chem; 2006 Jan; 4(1):61-6. PubMed ID: 16529550
[TBL] [Abstract][Full Text] [Related]
19. Ouabain antagonists as antihypertensive agents.
Ferrandi M; Barassi P; Molinari I; Torielli L; Tripodi G; Minotti E; Bianchi G; Ferrari P
Curr Pharm Des; 2005; 11(25):3301-5. PubMed ID: 16250857
[TBL] [Abstract][Full Text] [Related]
20. Adducin polymorphisms and the treatment of hypertension.
Manunta P; Citterio L; Lanzani C; Ferrandi M
Pharmacogenomics; 2007 May; 8(5):465-72. PubMed ID: 17465710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]